Search Medical Condition
Please enter condition
Please choose location

Emmendingen, Germany Clinical Trials

A listing of Emmendingen, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (66) clinical trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients

This study will evaluate the safety and efficacy of onabotulinumtoxinA for the treatment of urinary incontinence due to neurogenic detrusor overactivity in pediatric patients between the ages of 5 to 17 years.

Phase

0.6 miles

Learn More »

Tysabri Observational Program

TOP is an epidemiological observational study of participants receiving natalizumab, with each participant to be followed for up to 10 years. This study is designed to address the long-term safety profile and the long-term impact on disease activity and progression of natalizumab with marketed use, and the impact of treatment ...

Phase N/A

0.6 miles

Learn More »

Non-interventional Study With NOVOCART Inject in the Reconstruction of the Knee Cartilage Defects

Retrospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with localized full-thickness cartilage defects in the knee joint. Safety: Measuring the number of adverse drug reactions/serious adverse drug reactions since treatment and up to the present time. Efficacy: Evaluate symptoms and functional status at ...

Phase N/A

5.2 miles

Learn More »

Pregnancy Registry to Collect Long-Term Safety Data From Women Treated With HyQvia (Immune Globulin (Human) 10% With rHuPH20)

The purpose of this registry is to acquire safety data (including assessment of anti-rHuPH20 antibodies), regarding the course and outcome of pregnancy in women ever treated with HYQVIA. Development of the fetus/infant at birth and for the first 2 years will also be followed.

Phase N/A

5.34 miles

Learn More »

Tumour Registry Colorectal Cancer

The TKK is a prospective, longitudinal, nation wide cohort study with the purpose to record information on the antineoplastic treatment of colorectal cancer in Germany. The registry will follow patients for up to five years. It will identify common therapeutic sequences and changes in the treatment of the disease. At ...

Phase N/A

5.34 miles

Learn More »

One Pass thalamIc aNd subthalamIc stimulatiON

Tremor is the most salient symptom of Parkinson's disease (IPS=idiopathic Parkinson syndrome). Other symptoms are bradykinesia, rigidity and postural instability. As much as 75% of patients with IPS show resting tremor. Initially, tremor is typically unilateral and only visible in stress situation. In the later stage of the disease it ...

Phase N/A

6.91 miles

Learn More »

Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging

1. Study set up and Study design It will be an open, non-randomized prospective clinical pilot study to assess the value of contrast agents in venous thrombus investigations. a. Hypothesis - The relative signal intensity increase in decibel after intravenous contrast media injection as a tool to measure thrombus - ...

Phase N/A

6.91 miles

Learn More »

Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix and FOLFIRI in First Line (VALIDATE)

This is a non-interventional, prospective, open-label, single-arm, 3-cohort, multicenter study in Germany. In total, 1,240 patients will be enrolled in 100 oncological sites (office-based medical oncologists, oncology outpatient-centers, and university hospitals) in a time period of 36 months. Of these, 420 patients with high risk, 420 patients with intermediate risk, ...

Phase N/A

6.91 miles

Learn More »

Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease

This is a non-interventional, multinational, multi-center post-marketing study, to further document the safety and efficacy of pasireotide s.c. administered in routine clinical practice in patients with Cushing's disease. Patients with Cushing's disease and treated with pasireotide s.c. alone and in combination with other therapies will be monitored. For this study, ...

Phase N/A

7.82 miles

Learn More »

Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

This is a Phase 2/3, multicenter study of imetelstat that consists of 2 parts. Part 1 is an open‐label, single-arm design to assess the efficacy and safety of imetelstat. Approximately 55 participants will be enrolled in Part 1, including the expansion cohort, and be followed-up for safety, hematologic improvement and ...

Phase

7.82 miles

Learn More »